Description

Fenofibrate Choline is a choline salt of fenofibric acid, a lipid-modifying compound used in research models for the treatment of dyslipidemia and cardiovascular risk reduction. The sustained-release formulation offers extended bioavailability for pharmacokinetic and pharmacodynamic studies.

This product contains 135mg per capsule, 7 capsules per box, and is designed for in vitro and in vivo models investigating triglyceride reduction, HDL elevation, and peroxisome proliferator-activated receptor alpha (PPAR-?) activity.

Manufactured by Guangzhou Lianrui Pharmaceutical Co., Ltd. with Chinese NMPA approval number H20234080 and product code 86901062000093.

Fenofibrate Choline Product Specifications

Fenofibrate Choline Mechanism of Action & Research Applications

Fenofibric acid activates PPAR-? receptors, which regulate gene expression involved in lipid metabolism. This results in:

• Enhanced lipolysis and clearance of triglyceride-rich particles

• Reduced apolipoprotein C-III expression

• Increased HDL cholesterol production

Primary Research Applications Include:

• Dyslipidemia and metabolic disorder models

• Triglyceride-lowering pharmacology

• Atherogenic lipid profile investigations

• Combined statin and fibrate studies

• Liver enzyme modulation

Fenofibrate Choline Possible Side Effects (in lab studies)

• Liver enzyme elevation (ALT/AST)

• Gastrointestinal disturbances

• Muscle fatigue or myopathy

• Skin rash or photosensitivity

• Renal function fluctuation (in high doses)

Safety & Handling Instructions

• Use Restriction: Laboratory research use only

• Protective Measures: Wear gloves, lab coat, and safety glasses

• Storage: Store sealed, below 25°C, away from light and humidity

• Disposal: Dispose of according to institutional and local regulations

Research Use Disclaimer

This product is intended exclusively for laboratory research and is not approved for medical, diagnostic, or therapeutic use in humans or animals. Misuse may pose safety risks. Handle only in professionally equipped research settings.